MedPath

Sleep Apnea and Gestational Diabetes

Not Applicable
Completed
Conditions
Gestational Diabetes
Sleep Apnea
Registration Number
NCT02108197
Lead Sponsor
Ramathibodi Hospital
Brief Summary

The investigators hypothesize that pregnant women with gestational diabetes will have a high incidence of sleep apnea, and that the treatment of sleep apnea will lead to improved glucose control in these women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
82
Inclusion Criteria
  • gestational diabetes
Exclusion Criteria
  • pre-gestational diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
glucose tolerancetwo weeks

Measuring glucose, fructosamine and insulin levels following a mixed meal test at 0 and 2 weeks. Glucose and insulin will be measured at 0 minutes and every 30 minutes thereafter for 2 hours. Fructosamine will be measured at 0 minutes only.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine Ramathibodi Hospital

🇹🇭

Bangkok, Thailand

Faculty of Medicine Ramathibodi Hospital
🇹🇭Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.